locator iconlocator icon
All Labs
 
add to cart

Glycosylated Hemoglobin

440
4.8
NABL, CAP, ISO
ADD TO CART
Overview
Interpretations
FAQ's
Glycosylated Hemoglobin

Overview of Glycosylated Hemoglobin

What is Glycosylated Hemoglobin?

Glycosylated Hemoglobin, also called Glycated Hemoglobin, Hemoglobin A1c, or HbA1c, refers to hemoglobin which is bound to glucose. Glycosylated Hemoglobin Test is performed to measure the percentage of glycosylated hemoglobin in blood which reflects the average blood glucose over a period of past two to three months (8 - 12 weeks).

Sample Type

The sample type collected for Glycosylated Hemoglobin is: Blood

Preparation for Glycosylated Hemoglobin

  • No special preparation required

Why Get Tested for Glycosylated Hemoglobin?

The Glycosylated Hemoglobin test is performed to:

  • Monitor Diabetes treatment efficacy by measuring glycosylated hemoglobin regularly 

  • Screen for Diabetes as part of regular health checkup, as well as in patients with high risk of developing diabetes

  • Diagnose and confirm diabetes in combination with other tests if blood sugar levels are high over a long period of time


        

Understand more about Glycosylated Hemoglobin

Hemoglobin is the protein found in Red Blood Cells and is responsible for transporting oxygen. Of the different types of hemoglobin, Hemoglobin A is predominant. With elevation of blood sugar levels, some glucose binds spontaneously to Hemoglobin A (this binding is called Glycosylation or Glycation) and remains bound for the complete lifetime of the RBC, which is 120 days normally. Higher the level of glucose in the blood, greater is the amount of it binding to Hemoglobin A. Hemoglobin A1c is the dominant form of Glycated Hemoglobin. As RBCs die and are replaced, Hemoglobin A1c is cleared and slowly replaced with non-glycosylated hemoglobin. Measurement of HbA1c level over a period of time gives an indication of the level of glucose in the blood over the specified period of time. This helps in the diagnosis of Diabetes and is useful for monitoring the effectiveness of measures taken to reduce blood sugar levels.


What Results of Glycosylated Hemoglobin mean?

Interpretations

Normal: Below 5.7% (39 mmol/mol approx.)

Prediabetic: 5.7% - 6.4% (39 to 46 mmol/mol approx.)

Diabetic: Above 6.5% (above 48 mmol/mol approx.)


Less than 5.7% Glycated Hemoglobin indicates normal levels of blood sugar. Increased risk of developing Diabetes is found in Prediabetic patients with blood sugar level between 5.7% and 6.4%. Patients with a HbA1c level greater than 6.5% are usually diagnosed with Diabetes.


Patient Concerns about Glycosylated Hemoglobin

Frequently Asked Questions about Glycosylated Hemoglobin

Q. How is this test performed?
This test is performed on a blood sample. A syringe with a fine needle attached is used to withdraw blood sample from a blood vessel in your arm generally from the inner side of the elbow area. The doctor, nurse or the phlebotomist will tie an elastic band around your arm which will help the blood vessels to swell with blood and hence makes it easier to withdraw blood. You may be asked to tightly clench your fist. Once the veins are clearly visible, the area is cleaned with an antiseptic solution and then the needle is inserted into the blood vessel to collect the sample. You may feel a tiny pinprick during the procedure. Blood sample once collected is then sent to the laboratory.
Q. Is there any risk associated with this test?
There is no risk associated with the test. However, as this test involves a needle prick to withdraw the blood sample, rarely, a patient may experience increased bleeding, hematoma (blood collection under the skin) formation, bruising or infection at the site of needle prick.
+ more

Provided By

NABL

CAP

ISO

We focus on providing patients quality diagnostic healthcare services in India. Through our network, we offer patients convenient locations for their diagnostic healthcare services and efficient service. With over 3368 diagnostic and related healthcare tests and services offered, we believe we are capable of performing substantially all of the diagnostic healthcare tests and services currently prescribed by physicians in India. Our key competitive strengths are: Business model focused on the patient as a customer and an established consumer healthcare brand associated with quality services, in a market where patients generally choose their diagnostic healthcare service provider. Well-positioned to leverage upon one of the fastest-growing segments of the Indian healthcare industry. A network whose growth yields greater economies of scale, combined with a hub and spoke model that is scalable for further growth. Centralized information technology platform that fully integrates our network and is scalable. Attractive financial performance, financial profile and return on invested capital. Experienced leadership team with strong industry expertise and successful track record. Some of our laboratories have achieved International Organization for Standardization, or ISO, certification for their quality systems. Our National Reference Laboratory has obtained ISO 9001:2008 certification (for the performance of routine and advanced diagnostic pathology testing services, including clinical trials), ISO 15189:2007 (for quality management in medical laboratories), ISO 15189:2012 certification (in the field of medical testing) and ISO 27001:2013 certification (for establishing an effective information management system that maintains and processes information security at our data center).

Available at Other Labs